SRY	O
interference	O
of	O
normal	O
regulation	O
of	O
the	O
RET	O
gene	O
suggests	O
a	O
potential	O
role	O
of	O
the	O
Y	O
-	O
chromosome	O
gene	O
in	O
sexual	O
dimorphism	O
in	O
Hirschsprung	O
disease	O
.	O


The	O
Hirschsprung	O
disease	O
(	O
HSCR	O
)	O
is	O
a	O
complex	O
congenital	O
disorder	O
,	O
arising	O
from	O
abnormalities	O
in	O
enteric	O
nervous	O
system	O
(	O
ENS	O
)	O
development	O
.	O


There	O
is	O
a	O
gender	O
disparity	O
among	O
the	O
patients	O
,	O
with	O
the	O
male	O
to	O
female	O
ratio	O
as	O
high	O
as	O
5	O
:	O
1	O
.	O


Loss	O
-	O
of	O
-	O
function	O
mutations	O
of	O
HSCR	O
genes	O
and	O
haploinsufficiency	O
of	O
their	O
gene	O
products	O
are	O
the	O
primary	O
pathogenic	O
mechanisms	O
for	O
disease	O
development	O
.	O


Recent	O
studies	O
identified	O
over	O
half	O
of	O
the	O
HSCR	O
disease	O
susceptibility	O
genes	O
as	O
targets	O
for	O
the	O
sex	O
-	O
determining	O
factor	O
SRY	O
,	O
suggesting	O
that	O
this	O
Y	O
-	O
encoded	O
transcription	O
factor	O
could	O
be	O
involved	O
in	O
sexual	O
dimorphism	O
in	O
HSCR	O
.	O


Among	O
the	O
SRY	O
targets	O
,	O
the	O
tyrosine	O
kinase	O
receptor	O
RET	O
represents	O
the	O
most	O
important	O
disease	O
gene	O
,	O
whose	O
mutations	O
account	O
for	O
half	O
of	O
the	O
familial	O
and	O
up	O
to	O
one	O
-	O
third	O
of	O
the	O
sporadic	O
forms	O
of	O
HSCR	O
.	O


RET	O
is	O
regulated	O
by	O
a	O
distal	O
and	O
a	O
proximal	O
enhancer	O
at	O
its	O
promoter	S-PROMOTER
,	O
in	O
which	O
PAX3	O
and	O
NKX2	O
-	O
1	O
are	O
the	O
resident	O
transcription	O
factors	O
respectively	O
.	O


We	O
show	O
that	O
the	O
SRY	O
-	O
box	O
10	O
(	O
SOX10	O
)	O
co	O
-	O
activator	O
interacts	O
and	O
forms	O
transcriptional	O
complexes	O
with	O
PAX3	O
and	O
NKX2	O
-	O
1	O
in	O
a	O
sequence	O
-	O
independent	O
manner	O
and	O
exacerbates	O
their	O
respective	O
transactivation	O
activities	O
on	O
the	O
RET	B-PROMOTER
promoter	E-PROMOTER
.	O


SRY	O
competitively	O
displaces	O
SOX10	O
in	O
such	O
transcription	O
complexes	O
and	O
represses	O
their	O
regulatory	O
functions	O
on	O
RET	O
.	O


Hence	O
SRY	O
could	O
be	O
a	O
Y	O
-	O
located	O
negative	O
modifier	O
of	O
RET	O
expression	O
;	O
and	O
if	O
it	O
is	O
ectopically	O
expressed	O
during	O
ENS	O
development	O
,	O
such	O
SRY	O
repression	O
could	O
result	O
in	O
RET	O
protein	O
haploinsufficiency	O
and	O
promotion	O
of	O
HSCR	O
development	O
,	O
thereby	O
contributing	O
to	O
sexual	O
dimorphism	O
in	O
HSCR	O
.	O
